Showing 1 - 20 results of 57 for search 'Scott D Solomon', query time: 0.06s
Refine Results
-
1
Angiotensin II receptor blockade and ventricular remodelling by Nagesh S Anavekar, Scott D Solomon
Published 2005-03-01
Article -
2
Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control by Jelena P. Seferovic, Scott D. Solomon, Ellen W. Seely
Published 2020-12-01
Article -
3
Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease by Riccardo M. Inciardi, Scott D. Solomon, Paul M Ridker, Marco Metra
Published 2020-08-01
Article -
4
-
5
-
6
-
7
-
8
Investigating the Role of Interventricular Interdependence in Development of Right Heart Dysfunction During LVAD Support: A Patient-Specific Methods-Based Approach by Kevin L. Sack, Kevin L. Sack, Yaghoub Dabiri, Thomas Franz, Thomas Franz, Scott D. Solomon, Daniel Burkhoff, Julius M. Guccione
Published 2018-05-01
Article -
9
-
10
-
11
-
12
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension by Anne-Catherine Pouleur, Hajime Uno, Margaret F Prescott, Akshay Desai, Evan Appelbaum, Valentina Lukashevich, Beverly A Smith, Björn Dahlöf, Scott D Solomon
Published 2011-12-01
Article -
13
-
14
-
15
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan by Reza Mohebi, Yuxi Liu, Javed Butler, G. Michael Felker, Jonathan H. Ward, Margaret F. Prescott, Ileana L. Piña, Scott D. Solomon, James L. Januzzi Jr
Published 2023-10-01
Article -
16
A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram by Jasper Tromp, David Bauer, Brian L. Claggett, Matthew Frost, Mathias Bøtcher Iversen, Narayana Prasad, Mark C. Petrie, Martin G. Larson, Justin A. Ezekowitz, Scott D. Solomon
Published 2022-11-01
Article -
17
-
18
Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study by Magnus O. Wijkman, Marcus V.B. Malachias, Brian L. Claggett, Susan Cheng, Kunihiro Matsushita, Amil M. Shah, Pardeep S. Jhund, Josef Coresh, Scott D. Solomon, Orly Vardeny
Published 2021-10-01
Article -
19
An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality by Sara B. Seidelmann, Orly Vardeny, Brian Claggett, Bing Yu, Amil M. Shah, Christie M. Ballantyne, Elizabeth Selvin, Calum A. MacRae, Eric Boerwinkle, Scott D. Solomon
Published 2017-04-01
Article -
20
Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis. by Kanako Teramoto, Mário Santos, Brian Claggett, Jenine E John, Scott D Solomon, Dalane Kitzman, Aaron R Folsom, Mary Cushman, Kunihiro Matsushita, Hicham Skali, Amil M Shah
Published 2020-10-01
Article